Phoenix News Desk

Pancreatic Cancer Treatment Market Size Is Expected To Cross USD 4.2 Billion By 2025 : Grand View Research Inc.

 Breaking News
  • No posts were found

Pancreatic Cancer Treatment Market Size Is Expected To Cross USD 4.2 Billion By 2025 : Grand View Research Inc.

June 11
06:28 2019
Pancreatic Cancer Treatment Market Size Is Expected To Cross USD 4.2 Billion By 2025 : Grand View Research Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research,The rising prevalence of obesity, alcohol consumption, and smoking is expected to propel the industry growth of Pancreatic Cancer Treatment Market.

According to a report “Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2018 – 2025 ” published by Grand View Research, Inc.The global pancreatic cancer treatment market is expected to reach USD 4.2 billion in 2025, according to a new report by Grand View Research, Inc. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

Key Takeaways from the report:

The study suggests that exocrine cancer is by far the most common type of pancreatic cancer accounting for more than 95% of the overall pancreatic cancer types

Among the treatment types, targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells

North America dominated the segment with the largest revenue share in 2015 due to high adoption rate of advanced treatment options and highly developed healthcare infrastructure

Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, growing awareness regarding the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment

Some of the major companies operating in this market are, but are not limited to, Eli Lilly and Company; Celgene Corporation; F. Hoffmann-La Roche AG; Amgen, Inc.; Novartis AG; PharmaCyte Biotech, Inc.; Clovis Oncology; Teva Pharmaceutical Industries Ltd.; Merck & Co., Inc.; and Pfizer, Inc.

U.S. pancreatic cancer treatment market, by affected region, 2014-2025 (USD Million)

 U.S. pancreatic cancer treatment market, by affected region, 2014-2025 (USD Million)

Browse More Reports in Pharmaceuticals Industry:

 Anxiety Disorders And Depression Treatment MarketThe rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in the recent years.

Liposomal Doxorubicin MarketThe increasing number of mergers & acquisitions and partnerships for clinical trials on technologically advanced doxorubicin formulations will boost industry growth of Liposomal Doxorubicin Market.

Global pancreatic cancer treatment market, by type, 2015

Global pancreatic cancer treatment market, by type, 2015

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

Grand View Research has segmented the pancreatic cancer treatment market on the basis of affected region, treatment, and region:

Pancreatic Cancer Treatment Affected Region Outlook (Revenue, USD Million, 2014 – 2025)

  • Exocrine

  • Endocrine 

Pancreatic Cancer Treatment Outlook (Revenue, USD Million, 2014 – 2025)

  • Chemotherapy

  • Targeted Therapy

  • Others

Pancreatic Cancer Treatment Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

 

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/pancreatic-cancer-treatment-market